Abstract:ABSTRACT Lysostaphin is a peptidoglycan hydrolase secreted by Staphylococcus simulans . It can specifically lyse Staphylococcus aureus and is being tested as a novel antibacterial agent. The protein contains an N-terminal catalytic domain and a C-terminal cell wall targeting domain. Although the two domains from homologous enzymes were structurally determined, the structural organization of lysostaphin domains remains unknown. We used hydrogen/deuterium exchange mass spectrometry (H/DX-MS) and site-directed disulfide cross-linking to probe the interface between the lysostaphin catalytic and targeting domains. H/DX-MS-mediated comparison of peptides from full-length lysostaphin and the separated domains identified four peptides of lower solvent accessibility in the full-length protein. Cross-linking analysis using cysteine pair substitutions within those peptides showed that two pairs of cysteines can form disulfide bonds, supporting the domain association role of the targeted peptides. The cross-linked mutant exhibited a binding capacity to S. aureus that was similar to that of the wild-type protein but reduced bacteriolytic activity probably because of restraint in conformation. The diminished activity was further reduced with increasing NaCl concentrations that can cause contractions of bacterial peptidoglycan. The lytic activity, however, could be fully recovered by reducing the disulfide bonds. These results suggest that lysostaphin may require dynamic association of the two domains for coordinating substrate binding and target cleavage on the elastic peptidoglycan. Our study will help develop site-specific PEGylated lysostaphin to treat systemic S. aureus infections.

Characterization of Peptide Deformylase Homologues from Staphylococcus Epidermidis

Unique structural characteristics of peptide deformylase from pathogenic bacterium Leptospira interrogans.

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of E. coli Peptide Deformylase

3D-QSAR and Molecular Docking Studies of Hydroxamic Acids As Peptide Deformylase Inhibitors

Novel Conformational States of Peptide Deformylase from Pathogenic Bacterium Leptospira Interrogans

Investigation of Zinc-Containing Peptide Deformylase from Leptospira Interrogans by X-Ray Absorption Near-Edge Spectroscopy

Theoretical Study of the Catalytic Mechanism and Metal-Ion Dependence of Peptide Deformylase

H-Phosphonate Derivatives As Novel Peptide Deformylase Inhibitors

Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.

Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results

Characterization of a novel phage depolymerase specific to Escherichia coli O157:H7 and biofilm control on abiotic surfaces

Peptide Deformylase is a Potential Target for Anti-Helicobacter Pylori Drugs: Reverse Docking, Enzymatic Assay, and X-ray Crystallography Validation.

Potent and Selective Inhibitors of Staphylococcus Epidermidis Tryptophanyl-Trna Synthetase.

Design of novel analogues of t-DPH1 with reduced cytotoxicity, taking the three conserved characteristics of the Dermaseptin family as the feasible starting point

Characterization and Rational Design for Substrate Specificity of a Prolyl Endopeptidase from Stenotrophomonas Maltophilia.

Hydrogen/Deuterium Exchange Mass Spectrometry and Site-Directed Disulfide Cross-Linking Suggest an Important Dynamic Interface Between the Two Lysostaphin Domains

Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects

Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus

Prediction of the Binding Modes Between Macrolactin N and Peptide Deformylase from Staphylococcus Aureus by Molecular Docking and Molecular Dynamics Simulations

A Novel Polysaccharide Depolymerase Encoded by the Phage SH-KP152226 Confers Specific Activity Against Multidrug-Resistant Klebsiella Pneumoniae Via Biofilm Degradation